David Q. Pham, PharmD, BCPS, CDE, BC-ADM

PharmD 2001 University of the Pacific

Residency

Pharmacy Practice 2001-2002 St. Joseph's Medical Center

Board Certified-Advanced Diabetes Management (BC-ADM) 2016 American Association of Diabetes Educators

Certified Diabetes Educator (CDE) 2012 National Certification Board for Diabetes Educators

Board Certified Pharmacotherapy Specialist (BCPS) 2005 Board of Pharmaceutical Specialties

His interests include teaching, scholarship, and service to both the College of Pharmacy as well as the community.

Mary & Dick Allen Diabetes Center Hoag Hospital 520 Superior Ave., Suite 150 Newport Beach, CA 92663

This ambulatory care rotation allows third and fourth year Pharm.D. candidates to assist in the care and education of patients with diabetes mellitus at the Mary & Dick Allen Diabetes Center at Hoag Hospital.

He has been a member of the pharmacy faculty since August 2002.

Dr. Pham is very active in pharmacy organizations both at the local and state level.

Davies ML, Pham DQ, Drab SR. GLP1-RA add-on therapy in patients with type 2 diabetes currently on a bolus containing insulin regimen. Pharmacotherapy 2016; 36(8):893-905.

Kugler AJ, Fabbio KL, Pham DQ, Nadeau DA. Inhaled technosphere insulin: a novel delivery system and formulation for the treatment of types 1 and 2 diabetes mellitus. Pharmacotherapy 2015; 35:298-314.

Pham DQ, Nogid A, Plakogiannis R. Sitagliptin: a novel agent for the management of type 2 diabetes mellitus. American Journal of Health-System Pharmacy 2008;65:521-31.

Pham DQ, Cohen H, Chu V. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus. Journal of Clinical Pharmacology 2007;47:890-903.

Pham AQ, Kourlas H, Pham DQ. Cinnamon supplementation in type 2 diabetes mellitus. Pharmacotherapy 2007;27:595-9.

Nogid A, Pham DQ. Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus. Pharmacotherapy 2006;26:1626-40.